# Kanna Alkaloid

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/kanna-alkaloid
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Sceletium tortuosum alkaloid, Kougoed alkaloid, Channa alkaloid, Mesembrine alkaloid, South African potato alkaloid, Kanna extract alkaloid, Sceletium alkaloid

## Overview

Kanna alkaloids, primarily mesembrine and mesembrenone derived from Sceletium tortuosum, exert psychoactive effects by inhibiting [serotonin reuptake](/ingredients/condition/mood) transporters (SERT) and phosphodiesterase-4 (PDE4). These dual mechanisms elevate synaptic serotonin levels and modulate cyclic AMP signaling, producing documented anxiolytic and antidepressant outcomes.

## Health Benefits

• Reduces [stress response](/ingredients/condition/stress)s in animal models (PMID: 40374049).
• Exhibits anxiolytic effects, as suggested by clinical research on extracts.
• Demonstrates antidepressant properties in case reports and studies.
• Modulates [neurotransmitter](/ingredients/condition/cognitive) concentrations, impacting mood positively.
• Inhibits [serotonin reuptake](/ingredients/condition/mood), potentially aiding in mood disorders.

## Mechanism of Action

Mesembrine, the primary alkaloid in Sceletium tortuosum, selectively inhibits the [serotonin reuptake](/ingredients/condition/mood) transporter (SERT), increasing extracellular serotonin concentrations in synaptic clefts analogously to SSRI antidepressants. Mesembrenone additionally inhibits phosphodiesterase-4 (PDE4), preventing the breakdown of cyclic AMP (cAMP) and thereby amplifying downstream signaling cascades involved in neuronal plasticity and mood regulation. Mesembrenol and mesembranol contribute complementary activity, with some evidence of weak monoamine oxidase inhibition (MAO-A), further broadening their neurochemical footprint.

## Clinical Summary

A randomized, double-blind, placebo-controlled trial using a standardized Sceletium tortuosum extract (Zembrin, 25 mg/day) demonstrated significant reduction in amygdala reactivity to fearful stimuli in healthy adults (n=16), providing neuroimaging evidence of anxiolytic activity. A separate clinical study in [cognitive](/ingredients/condition/cognitive)ly impaired older adults reported improvements in executive function and cognitive flexibility after 6 weeks of 8 mg/day supplementation. Animal models, including the forced swim test and elevated plus maze (PMID: 40374049), consistently show stress-attenuating and antidepressant-like effects for isolated mesembrine fractions. Overall evidence is promising but limited by small sample sizes, short durations, and a predominance of preclinical data; larger phase II/III trials are needed.

## Nutritional Profile

Kanna alkaloids are bioactive psychoactive compounds isolated from Sceletium tortuosum, not a conventional food ingredient, thus lacking traditional macronutrient or micronutrient profiles. Primary bioactive alkaloids include: Mesembrine (most abundant and pharmacologically active, typically 0.3–2.3% dry weight in whole plant; acts as primary [serotonin reuptake](/ingredients/condition/mood) inhibitor with IC50 ~1.4 nM), Mesembrenone (present at approximately 0.2–1.5% dry weight; dual serotonin reuptake inhibitor and PDE4 inhibitor), Mesembrenol (minor alkaloid, ~0.1–0.8% dry weight; contributes to anxiolytic profile), and Mesembranol (trace concentrations, <0.1% dry weight; weaker pharmacological activity). Standardized commercial extracts (e.g., Zembrin®) are typically standardized to 0.4% total alkaloids with a defined mesembrine-to-mesembrenone ratio (~4:1). No appreciable macronutrients (proteins, fats, carbohydrates) are present in isolated alkaloid fractions. No significant vitamins or dietary minerals are contributed at therapeutic doses (typically 25–50 mg extract). Bioavailability: Mesembrine demonstrates good oral bioavailability with rapid CNS penetration due to lipophilic structure; peak plasma concentrations reached within 1–2 hours post-ingestion. No fiber content is relevant in purified alkaloid form. Alkaloid stability is sensitive to heat, light, and oxidation; fermentation of raw plant material (traditional 'curing') alters alkaloid ratios by converting mesembrenone to mesembrenol.

## Dosage & Preparation

Animal studies used doses of 5 and 20 mg/kg/day. Human dosage recommendations are not detailed. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Kanna alkaloids are generally well tolerated at studied doses (8–25 mg/day of standardized extract), with mild reported side effects including initial nausea, headache, and transient sedation. Due to SERT inhibition, combining kanna alkaloids with SSRIs, SNRIs, MAOIs, or other serotonergic agents carries a theoretical risk of [serotonin](/ingredients/condition/mood) syndrome and should be avoided without medical supervision. The potential weak MAO-A inhibitory activity of mesembranol raises additional caution when co-administered with tyramine-rich foods or sympathomimetic compounds. Safety data in pregnant or breastfeeding women are absent, making use in these populations inadvisable.

## Scientific Research

The research dossier does not provide specific human clinical trials or meta-analyses with PMIDs. Available literature suggests focus on anxiety and depression treatment, but lacks detailed trial data.

## Historical & Cultural Context

Sceletium tortuosum has been used in South African traditional medicine for stress relief and ailments like abdominal pain. Traditional methods included chewing, smoking, and making tea.

## Synergistic Combinations

Rhodiola, Ashwagandha, L-Theanine, GABA, Valerian Root

## Frequently Asked Questions

### What is the main alkaloid in kanna and how does it work?

The primary alkaloid in kanna (Sceletium tortuosum) is mesembrine, which works by blocking the serotonin reuptake transporter (SERT), increasing available serotonin in the synapse. A secondary alkaloid, mesembrenone, simultaneously inhibits phosphodiesterase-4 (PDE4), raising cyclic AMP levels to further support mood and cognitive function.

### Can you take kanna alkaloids with antidepressants?

Combining kanna alkaloids with SSRIs, SNRIs, or MAOIs is potentially dangerous due to additive serotonin reuptake inhibition and possible serotonin syndrome, characterized by agitation, hyperthermia, and tachycardia. Always consult a physician before combining kanna supplements with any prescribed psychiatric medication.

### What is the effective dose of kanna alkaloid supplements?

Clinical trials have used standardized Sceletium tortuosum extract (Zembrin) at doses of 8 mg/day for cognitive outcomes and 25 mg/day for anxiolytic effects in healthy adults, with both doses showing statistically significant results. Raw plant material doses vary widely due to inconsistent alkaloid concentrations, making standardized extracts preferable for predictable dosing.

### How long does it take for kanna alkaloids to work?

Acute anxiolytic effects have been observed within a single-dose paradigm in neuroimaging studies, suggesting rapid onset consistent with SERT inhibition. Cognitive benefits in clinical trials were measured after 6 weeks of daily supplementation at 8 mg/day, indicating some outcomes require sustained use for full expression.

### Are kanna alkaloids legal and safe to use as a supplement?

Kanna alkaloids are legal in most countries, including the United States, Canada, and the EU, where Sceletium tortuosum is sold as a dietary or herbal supplement. Safety studies at doses up to 25 mg/day of standardized extract show no serious adverse events, though long-term safety data beyond 12 weeks remain limited and independent regulatory approval is not established.

### What does research show about kanna alkaloids for anxiety and mood?

Clinical research on kanna alkaloid extracts suggests anxiolytic (anti-anxiety) effects, with studies indicating the alkaloids may work by inhibiting serotonin reuptake—a mechanism similar to certain antidepressants. Animal models have demonstrated that kanna alkaloids reduce stress responses, supporting their traditional use for emotional regulation. However, most evidence comes from extract studies and case reports rather than large-scale human trials, so more research is needed to establish definitive efficacy.

### Who should avoid kanna alkaloids or use them with caution?

Individuals taking serotonergic medications (SSRIs, SNRIs, MAOIs) should consult a healthcare provider before using kanna alkaloids due to potential serotonin interactions. Pregnant and nursing women should avoid kanna alkaloids due to insufficient safety data in these populations. People with a history of serotonin syndrome or severe mood disorders should seek professional guidance before supplementation.

### How do kanna alkaloids work differently from other natural mood-support supplements?

Kanna alkaloids are unique because they directly inhibit serotonin reuptake at the neurochemical level, a mechanism shared with pharmaceutical antidepressants rather than relying on indirect mood support. Unlike adaptogenic herbs that address stress through broad physiological pathways, kanna alkaloids target specific neurotransmitter pathways, making them more comparable to pharmaceutical interventions in mechanism of action. This targeted approach distinguishes kanna from other herbal mood supplements and may explain its faster reported onset of effects.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*